Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indoximod With Chemotherapy and Radiation for Children With Progressive Brain Tumors or Newly Diagnosed DIPG
NCT04049669Phase 2Active, not recruiting
- Start
- Oct 2019
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indoximod in glioblastoma (GBM), medulloblastoma, ependymoma, diffuse intrinsic pontine glioma (DIPG). Started Oct 2019; status: active, not recruiting.
02
Drugs
indoximod
03
Conditions
glioblastoma (GBM)medulloblastomaependymomadiffuse intrinsic pontine glioma (DIPG)
Beyond the preview
Go deeper on NCT04049669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04049669.